Vicapsys Life Sciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OTC.Pink
Wildcat Capital Management, Wildcat Partner Holdings, and Leonard A. Potter have jointly disclosed a beneficial ownership of 18.8% of Vicapsys Life Sciences, Inc.'s common stock.